HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
MRNA Moderna
- 35.750
- +2.760+8.37%
Close Feb 18 16:00 ET
- 35.800
- +0.050+0.14%
Post 18:19 ET
13.76BMarket Cap-3.85P/E (TTM)
36.980High32.042Low18.95MVolume33.050Open32.990Pre Close673.27MTurnover5.46%Turnover RatioLossP/E (Static)384.82MShares170.47052wk High1.26P/B12.41BFloat Cap29.25052wk Low--Dividend TTM347.11MShs Float497.490Historical High--Div YieldTTM14.97%Amplitude11.540Historical Low35.525Avg Price1Lot Size
Moderna Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 3.66%-3B | 32.64%825M | 2.13%-1.57B | -39.23%-1.27B | 19.27%-989M | -162.60%-3.12B | -62.58%622M | -734.92%-1.6B | -400.99%-915M | -144.34%-1.23B |
| Net income from continuing operations | 24.46%-3.56B | -616.13%-1.12B | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M |
| Operating gains losses | 48.57%52M | -52.63%9M | -75.76%8M | 162.86%22M | -27.78%13M | --35M | --19M | --33M | ---35M | --18M |
| Depreciation and amortization | -69.57%189M | -70.30%60M | -79.12%52M | -55.43%41M | -53.85%36M | 78.45%621M | 152.50%202M | 120.35%249M | 21.05%92M | -1.27%78M |
| Deferred tax | ---- | ---- | --0 | --0 | --0 | 248.12%828M | -23.26%-106M | 1,609.28%1.46B | 4.35%-220M | -112.33%-310M |
| Other non cash items | 757.14%60M | 400.00%54M | -102.70%-1M | 150.00%4M | 175.00%3M | -75.00%7M | -125.00%-18M | 76.19%37M | ---8M | ---4M |
| Change In working capital | 43.88%-78M | 597.59%1.74B | -1,050.00%-1.73B | -125.44%-146M | 105.24%60M | 95.98%-139M | 62.75%249M | 120.13%182M | 131.63%574M | -28.68%-1.14B |
| -Change in receivables | 8.32%534M | 23.82%1.21B | 14.26%-1.4B | -102.95%-26M | 177.57%755M | -72.46%493M | -25.65%974M | -40,750.00%-1.63B | 82.40%881M | 27,100.00%272M |
| -Change in inventory | -88.89%83M | 2.11%291M | -104.82%-11M | -677.78%-104M | -143.06%-93M | 51.83%747M | -74.73%285M | 246.15%228M | -14.29%18M | 143.11%216M |
| -Change in prepaid assets | -85.11%145M | 44.55%292M | -116.41%-150M | --0 | 101.42%3M | 157.33%974M | 119.61%202M | 364.93%914M | -22.22%70M | 48.79%-212M |
| -Change in payables and accrued expense | -45.51%-454M | 132.53%122M | -83.82%143M | 96.92%-7M | -19.87%-712M | -1,400.00%-312M | -195.91%-375M | 1,093.26%884M | 78.84%-227M | -174.72%-594M |
| -Change in other current assets | 91.24%-53M | -80.77%10M | 99.85%-1M | -500.00%-78M | 300.00%16M | -2,980.95%-605M | 750.00%52M | -7,300.00%-648M | -230.00%-13M | -60.00%4M |
| -Change in other current liabilities | -83.01%106M | 4,000.00%78M | -97.78%14M | -2,300.00%-110M | 1,227.27%124M | 743.24%624M | 98.84%-2M | 31,500.00%632M | -97.72%5M | -144.00%-11M |
| -Change in other working capital | 78.69%-439M | 70.46%-262M | -66.49%-323M | 211.88%179M | 95.97%-33M | 50.45%-2.06B | 39.50%-887M | 39.56%-194M | 89.78%-160M | -1.74%-819M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 3.66%-3B | 32.64%825M | 2.13%-1.57B | -39.23%-1.27B | 19.27%-989M | -162.60%-3.12B | -62.58%622M | -734.92%-1.6B | -400.99%-915M | -144.34%-1.23B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -53.66%1.95B | -0.19%-539M | -8.62%721M | -15.17%1.65B | -94.13%118M | 181.26%4.21B | 48.66%-538M | -16.51%789M | 268.75%1.94B | 151.29%2.01B |
| Net PPE purchase and sale | -48.66%-1.05B | -137.27%-522M | -7.86%-151M | 22.22%-182M | -73.45%-196M | -76.75%-707M | -139.13%-220M | -57.30%-140M | -168.97%-234M | 14.39%-113M |
| Net business purchase and sale | --0 | --0 | --0 | --0 | --0 | ---85M | --0 | --0 | --0 | ---85M |
| Net investment purchase and sale | -40.25%3B | 94.24%-17M | -6.14%872M | -15.93%1.83B | -85.79%314M | 206.02%5.02B | 67.79%-295M | -10.15%929M | 304.51%2.18B | 158.30%2.21B |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | 42.50%-23M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -53.66%1.95B | -0.19%-539M | -8.62%721M | -15.17%1.65B | -94.13%118M | 181.26%4.21B | 48.66%-538M | -16.51%789M | 268.75%1.94B | 151.29%2.01B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 104.07%56M | 97.25%-3M | 118.97%11M | 105.09%34M | 102.58%14M | 60.06%-1.38B | 75.11%-109M | 94.43%-58M | 49.66%-668M | 15.58%-542M |
| Net issuance payments of debt | 96.30%-10M | 88.71%-14M | 104.62%3M | 103.57%2M | 96.00%-1M | -46.74%-270M | -103.28%-124M | -41.30%-65M | -21.74%-56M | 19.35%-25M |
| Net common stock issuance | 105.96%66M | -26.67%11M | 14.29%8M | 105.23%32M | 102.90%15M | 66.08%-1.11B | 103.98%15M | 100.70%7M | 52.22%-612M | 15.38%-517M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 104.07%56M | 97.25%-3M | 118.97%11M | 105.09%34M | 102.58%14M | 60.06%-1.38B | 75.11%-109M | 94.43%-58M | 49.66%-668M | 15.58%-542M |
| Net cash flow | ||||||||||
| Beginning cash position | -8.98%2.93B | -44.23%1.65B | -35.11%2.48B | -40.16%2.07B | -8.98%2.93B | -53.10%3.22B | -2.89%2.95B | 32.48%3.82B | -31.60%3.46B | -53.10%3.22B |
| Current changes in cash | -245.67%-999M | 1,228.00%282M | 4.14%-833M | 13.30%409M | -451.23%-857M | 92.07%-289M | -114.20%-25M | -657.05%-869M | 116.60%361M | 113.56%244M |
| End cash Position | -34.12%1.93B | -34.12%1.93B | -44.23%1.65B | -35.11%2.48B | -40.16%2.07B | -8.98%2.93B | -8.98%2.93B | -2.89%2.95B | 32.48%3.82B | -31.60%3.46B |
| Free cash flow | -6.01%-4.06B | -24.63%303M | 1.32%-1.72B | -26.72%-1.46B | 11.43%-1.19B | -183.50%-3.83B | -74.39%402M | -1,167.48%-1.74B | -629.49%-1.15B | -150.86%-1.34B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Moo Live
Feb 12 16:30
Alibaba Group Q4 FY2024 earnings conference call